Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -5.08% | +3.70% |
2020 | Mark Corrigan Departs as CEO from Correvio Pharma Corp | CI |
2020 | Justin Renz, CFO Departs from Correvio Pharma Corp | CI |
Chart calendar Correvio Pharma Corp.
Upcoming events on Correvio Pharma Corp.
No events available
Past events on Correvio Pharma Corp.
29/06/2020 | Q1 2020 Earnings Release |
15/05/2020 10:30 pm | Annual General Meeting |
30/03/2020 04:30 pm | FY 2019 Earnings Release |
03/12/2019 11:20 pm | Piper Jaffray Healthcare Conference |
18/11/2019 10:00 pm | American Heart Association Scientific Meeting - Poster #2028 |
14/11/2019 07:00 pm | Q3 2019 Earnings Call |
14/11/2019 05:30 pm | Q3 2019 Earnings Release |
04/10/2019 08:10 pm | Cantor Global Health Care Conference |
10/09/2019 11:15 pm | H.C. Wainwright Global Investor Conference |
02/09/2019 05:30 pm | European Society of Cardiology Congress |
31/08/2019 | European Society of Cardiology Congress |
14/08/2019 06:00 pm | Interim 2019 Earnings Call |
14/08/2019 04:30 pm | Interim 2019 Earnings Release |
18/06/2019 10:00 pm | Annual General Meeting |
08/05/2019 06:00 pm | Q1 2019 Earnings Call |
08/05/2019 05:30 pm | Q1 2019 Earnings Release |
16/04/2019 04:00 pm | European Clinical Microbiology and Infectious Disease Congress - Poster Number: #P2849 |
16/04/2019 04:00 pm | European Clinical Microbiology and Infectious Disease Congress - Poster Number: #P2296 |
15/04/2019 07:30 pm | European Clinical Microbiology and Infectious Disease Congress - Oral Presentation Number 00920 |
15/04/2019 05:00 pm | European Clinical Microbiology and Infectious Disease Congress - Poster Number: #P1865 |
Annual results
Fiscal Period | December | 2015 | 2016 | 2017 | 2018 | 2019 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 20,8 23,6 -11.91% | 25,3 24,5 3.07% | 24,0 24,9 -3.48% | 28,7 28,1 2.06% | 32,6 32,8 -0.65% |
EBITDA Million USD | Released Forecast Spread | -19,9 -16,7 -18.86% | -11,6 -11,7 1.16% | -19,5 -19,2 -1.36% | -22,2 -24,8 10.49% | -23,5 -23,4 -0.38% |
EBIT Million USD | Released Forecast Spread | -22,1 -18,7 -18.26% | -14,6 -13,5 -7.76% | -23,0 -21,0 -9.59% | -26,3 -27,8 5.15% | -27,5 -26,6 -3.36% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,5 -20,4 -19.81% | -19,5 -18,1 -7.65% | -29,4 -27,0 -9.11% | -16,5 -16,1 -2.81% | -35,0 -35,5 1.29% |
Net income Million USD | Released Forecast Spread | -24,5 -21,5 -13.88% | -19,6 -18,4 -6.68% | -29,8 -27,1 -10.14% | -16,6 -16,2 -2.37% | -35,2 -34,7 -1.34% |
EPS USD | Released Forecast Spread | -1,34 -1,19 -12.84% | -0,78 -0,72 -8.59% | -0,90 -0,84 -7.78% | -0,47 -0,47 -0.43% | -0,79 -0,78 -1.72% |
Announcement Date | 10/03/16 | 07/03/17 | 13/03/18 | 13/03/19 | 30/03/20 |
Past sector events for Correvio Pharma Corp.
23/05/2024 10:30 am | CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release |
15/05/2024 10:30 am | MERCK KGAA: Q1 2024 Earnings Release |
14/05/2024 | OSCOTEC INC.: Q1 2024 Earnings Release |
14/05/2024 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release |
09/05/2024 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
09/05/2024 01:35 am | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
07/05/2024 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
07/05/2024 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
30/04/2024 | YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release |
30/04/2024 | HK INNO.N CORPORATION: Q1 2024 Earnings Release |
- Stock Market
- Equities
- CORV Stock
- Calendar Correvio Pharma Corp.